Bank of Nova Scotia’s Allergan Inc AGN Stock Holding History

Bank of Nova Scotia’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,076	Closed	-$1.08M	–	635
2014 Q4	$1.08M	Buy	5,076 +150	+3%	+$29.8K	﹤0.01%	273
2014 Q3	$878K	Buy	4,926 +235	+5%	+$39K	﹤0.01%	296
2014 Q2	$794K	Buy	4,691 +299	+7%	+$46.6K	﹤0.01%	299
2014 Q1	$545K	Buy	4,392 +252	+6%	+$30.7K	﹤0.01%	366
2013 Q4	$460K	Buy	4,140 +248	+6%	+$23.7K	﹤0.01%	397
2013 Q3	$351K	Sell	3,892 -387	-9%	-$34.7K	﹤0.01%	390
2013 Q2	$360K	Buy	+4,279	New	+$444K	﹤0.01%	356

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Bank of Nova Scotia's AGN Position: Q1 2015 in Review

Bank of Nova Scotia sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 5,076 shares — an estimated $1.08M sold.

Bank of Nova Scotia first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.08M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Bank of Nova Scotia reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Bank of Nova Scotia sold 5,076 Allergan Inc shares in Q1 2015, an estimated $1.08M.
Bank of Nova Scotia first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Bank of Nova Scotia's Allergan Inc position peaked at $1.08M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Bank of Nova Scotia's 13F filing for Q1 2015, filed 15 May 2015.